Data to Discovery. Go Beyond.

Cordis returns to TCT 2025 with a powerful lineup—from late-breaking clinical data to hands-on engagement with our trusted global portfolio.

Join us in San Francisco to experience the science and people shaping cardiovascular care.

Request Additional Information

Explore our portfolio, up close.

Book time with a Cordis expert for a hands-on demo or a one-on-one conversation tailored to your clinical needs.
 

Schedule a demo or meeting

Join us for a night of connection and celebration.

Unwind with colleagues and industry leaders at our exclusive reception during TCT—great conversations, great company, and a toast to what’s ahead.

RSVP

See the data everyone will be talking about.

Don’t miss the late-breaking session featuring 12 month clinical results for SELUTION4ISR and SELUTION DeNovo trials.
 

Add to Calendar

A New Era in Drug Elution

Join an unfiltered discussion on the 12-month Results from SELUTION4ISR and SELUTON DeNovo trials.

Add Event to Calendar

Learn More

Select your region to access clinical information tailored to your location and regulatory environment.

US Healthcare Professionals International Healthcare Professionals

The Latest News from Cordis

May 19, 2025

Cordis Launches Global Coronary Registry for SELUTION SLR™ Drug-Eluting Balloon

This Global Coronary Registry will enroll up to 10,000 patients worldwide and will be one of the largest coronary drug-eluting balloon registries to date.

Read more

Apr 24, 2025

Cordis Announces Positive Results from Two Major Clinical Studies.

Cordis Announces Positive Results from Two Major Studies Demonstrating Durable Efficacy of SELUTION SLR Drug-Eluting Balloon in Complex Peripheral Artery Disease Patients.

Read more

Jul 16, 2024

Cordis Awarded Vascular Closure Devices Agreement with Premier, Inc. for MYNX CONTROL™ VENOUS Vascular Closure Device

Read more